NKCFO LLC’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,075	Closed	-$49K	–	73
2023 Q3	$49K	Hold	1,075	–	–	0.03%	74
2023 Q2	$60K	Buy	+1,075	New	+$60K	0.03%	76